Early detection and subtyping of gastric cancer: A cell-free DNA fragmentome-based liquid biopsy method
Year: 2026
Type: article
Abstract: Cell-free DNA (cfDNA) in plasma provides attractive opportunities for early cancer diagnosis. This study aimed to establish gastric cancer (GC) artificial intelligence algorithms (GC-AIAs) based on cfDNA fragmentome for GC's early detection and subtyping. Whole-genome sequencing data were obtained from the training cohort of 404 participants, the internal testing cohort of 173 participants, and the independent validation cohort of 299 participants. Seven classes of cfDNA fragmentomic features were analyzed and employed to build the GC-AIA employing a stack ensemble model. The model's AUC in the internal testing cohort was 0.958 (95% confidence interval [CI]: 0.931-0.985) and that in the independent validation cohort was 0.951 (95% CI: 0.926-0.975). The GC-AIA showed high performance for various staged/differentiated GC detection and molecular subtyping. The stage shift analysis showed a notable increase in diagnosed stage Ⅰ patients. Our methodology built on the cfDNA fragmentomics exhibited encouraging preliminary performance in early detection and subtyping of GC patients.
Source: iScience
Institutions: Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine, Chinese Academy of Sciences, Sichuan Center for Disease Control and Prevention, Sichuan University, West China Hospital of Sichuan University, Tongji University, Yangpu Hospital of Tongji University, Jinzhou Central Hospital, University of California, Davis, Zhejiang University
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $3,240
Awards: G5075379725, G6022309094, G7363355697
OpenAlex ID: W7155185111
